Australian Ovarian Cancer Study Group
study group
Ratings
0
Nobody has rated this yet. Be the first!
Works
10
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study
Whole-genome characterization of chemoresistant ovarian cancer
Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development
Erratum: Corrigendum: Whole–genome characterization of chemoresistant ovarian cancer